文献速递生殖医学

遗传亲缘关系的相对重要性

The relative importance of genetic parenthood.
PubMed 文献 · Reprod Biomed Online · 2019-03-12

该离散选择实验于2015至2016年在荷兰和比利时的173例重度不孕患者和111名妇产科医生中开展,评估遗传亲缘关系相对于妊娠率、治愈不孕、母体健康、子代健康和费用等治疗特征的重要性。结果显示遗传亲缘关系不影响患者的治疗偏好,对医生偏好的影响小于所有其他特征。

要点

  • 在重度不孕患者中,治疗能否实现遗传亲缘关系不影响其治疗偏好(n=173)。
  • 遗传亲缘关系对妇产科医生治疗偏好的影响小于所有其他治疗特征(n=111)。
  • 患者愿以放弃遗传亲缘关系换取子代健康风险降低3.6%、费用降低3500欧元、卵巢过度刺激风险降低4.6%、母体癌症风险降低2.7%或妊娠率提高18%。

核心结论

  • 在等待更大规模人群重复验证的同时,这些发现挑战了遗传亲缘关系具有主导重要性的假设。
  • 这引发了关于是否可在治疗轨迹更早阶段将供卵/供精作为有价值的替代方案,以及投资如体外配子发生等实现遗传亲缘关系的新技术是否与其未来临床效果成比例的疑问。

研究设计与样本

  • 离散选择实验,纳入的治疗特征包括遗传亲缘关系、妊娠率、治愈不孕、母体健康、子代健康和费用。
  • 问卷于2015年至2016年在荷兰和比利时的重度不孕患者及其妇产科医生中发放。
  • 问卷由173例患者和111名妇产科医生完成。

主要发现

  • 在选择安全、有效性和费用不同的治疗时,治疗实现遗传亲缘关系的能力不影响重度不孕患者的治疗偏好(n=173)。
  • 遗传亲缘关系对妇产科医生治疗偏好的影响小于所有其他治疗特征(n=111)。
  • 患者表示愿意换用无法实现遗传亲缘关系的治疗,以换取子代健康风险降低3.6%、费用降低3500欧元、卵巢过度刺激风险降低4.6%、母体癌症风险降低2.7%或妊娠率提高18%。
  • 妇产科医生做出了类似的权衡。

临床怎么用

  • 作者认为这些发现挑战了遗传亲缘关系具有主导重要性的假设,并提出是否可在治疗轨迹更早阶段将供卵/供精作为有价值的替代方案,以及投资如体外配子发生等新技术是否与其未来临床效果成比例的疑问。

局限性

  • 作者指出需在更大规模人群中重复验证本研究(原文:awaiting replication of this study in larger populations)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

RESEARCH QUESTION: How much do patients with severe infertility and their gynaecologists value genetic parenthood relative to other key treatment characteristics? DESIGN: A discrete choice experiment included the following treatment characteristics: genetic parenthood, pregnancy rate, curing infertility, maternal health, child health and costs. The questionnaire was disseminated between 2015 and 2016 among Dutch and Belgian patients with severe infertility and their gynaecologists. RESULTS: The questionnaire was completed by 173 patients and 111 gynaecologists. When choosing between treatments that varied in safety, effectiveness and costs, the treatment's ability to lead to genetic parenthood did not affect the treatment preference of patients with severe infertility (n = 173). Genetic parenthood affected the treatment preference of gynaecologists (n = 111) less than all other treatment characteristics. Patients indicated that they would switch to a treatment that did not enable genetic parenthood in return for a child health risk reduction of 3.6%, a cost reduction of €3500, an ovarian hyperstimulation risk reduction of 4.6%, a maternal cancer risk reduction of 2.7% or a pregnancy rate increase of 18%. Gynaecologists made similar trade-offs. CONCLUSIONS: While awaiting replication of this study in larger populations, these findings challenge the presumed dominant importance of genetic parenthood. This raises questions about whether donor gametes could be presented as a worthy alternative earlier in treatment trajectories and whether investments in novel treatments enabling genetic parenthood, like in-vitro gametogenesis, are proportional to their future clinical effect.

来源:Reprod Biomed Online,查看原文。版权归原作者所有。

引用

  1. Hendriks S, van Wely M, D'Hooghe TM, et al. The relative importance of genetic parenthood. Reprod Biomed Online. 2019. PMID: 31006544. doi:10.1016/j.rbmo.2019.02.008

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。